Key Statistics for Colorectal Cancer 2022 [Available from: https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html. Accessed 11/1/2022.

Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64.

Article  PubMed  Google Scholar 

Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255(5):922–8.

Article  PubMed  Google Scholar 

Juul T, Ahlberg M, Biondo S, Espin E, Jimenez LM, Matzel KE, et al. Low anterior resection syndrome and quality of life: an international multicenter study. Dis Colon Rectum. 2014;57(5):585–91.

Article  PubMed  Google Scholar 

Bakx R, Busch OR, Bemelman WA, Veldink GJ, Slors JF, van Lanschot JJ. Morbidity of temporary loop ileostomies. Dig Surg. 2004;21(4):277–81.

Article  CAS  PubMed  Google Scholar 

Nasvall P, Dahlstrand U, Lowenmark T, Rutegard J, Gunnarsson U, Strigard K. Quality of life in patients with a permanent stoma after rectal cancer surgery. Qual Life Res. 2017;26(1):55–64.

Article  PubMed  Google Scholar 

Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–7 (discussion 7-8).

Article  PubMed  PubMed Central  Google Scholar 

Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633–40.

Article  PubMed  Google Scholar 

Martens MH, Maas M, Heijnen LA, Lambregts DM, Leijtens JW, Stassen LP, et al. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst. 2016;108(12).

Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174–83.

Article  PubMed  Google Scholar 

van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–45.

Article  PubMed  Google Scholar 

Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(7):501–13.

Article  PubMed  Google Scholar 

Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546–56.

Article  CAS  PubMed  Google Scholar 

Hupkens BJP, Martens MH, Stoot JH, Berbee M, Melenhorst J, Beets-Tan RG, et al. Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection - a matched-controlled study. Dis Colon Rectum. 2017;60(10):1032–40.

Article  PubMed  Google Scholar 

Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3(12):825–36.

Article  PubMed  Google Scholar 

Appelt AL, Ploen J, Vogelius IR, Bentzen SM, Jakobsen A. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(1):74–80.

Article  PubMed  Google Scholar 

Appelt A, Jakobsen A, Gerard JP, Sebag-Montefiore D. Is there a radiation dose-response relationship for non-operative management of rectal cancer? Radiother Oncol. 2020;152:S76–7.

Article  Google Scholar 

Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S123–9.

Article  PubMed  PubMed Central  Google Scholar 

Hudson EM, Noutch S, Brown S, Adapala R, Bach SP, Burnett C, et al. A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. BMJ Open. 2022;12(4):e049119.

Article  PubMed  PubMed Central  Google Scholar 

Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96–02 randomized trial. J Clin Oncol. 2004;22(12):2404–9.

Article  PubMed  Google Scholar 

Sun Myint A, Smith FM, Gollins SW, Wong H, Rao C, Whitmarsh K, et al. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation? Br J Radiol. 2017;90(1080):20170175.

Article  PubMed  PubMed Central  Google Scholar 

Habr-Gama A, Sao Juliao GP, Gama-Rodrigues J, Vailati BB, Ortega C, Fernandez LM, et al. Baseline T classification predicts early tumor regrowth after nonoperative management in distal rectal cancer after extended neoadjuvant chemoradiation and initial complete clinical response. Dis Colon Rectum. 2017;60(6):586–94.

Article  PubMed  Google Scholar 

Sun Myint A, Smith FM, Gollins S, Wong H, Rao C, Whitmarsh K, et al. Dose escalation using contact X-ray brachytherapy after external beam radiotherapy as nonsurgical treatment option for rectal cancer: outcomes from a single-center experience. Int J Radiat Oncol Biol Phys. 2018;100(3):565–73.

Article  PubMed  Google Scholar 

Gerard JP, Barbet N, Gal J, Dejean C, Evesque L, Doyen J, et al. Planned organ preservation for early T2–3 rectal adenocarcinoma: a French, multicentre study. Eur J Cancer. 2019;108:1–16.

Article  PubMed  Google Scholar 

Gerard JP, Azria D, Gourgou-Bourgade S, Martel-Lafay I, Hennequin C, Etienne PL, et al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol. 2012;30(36):4558–65.

Article  CAS  PubMed  Google Scholar 

Gerard JP, Montagne L, Thamphya B, Doyen J, Schiappa R, Benezery K, et al. Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer. Clin Transl Radiat Oncol. 2022;33:70–6.

Article  PubMed  PubMed Central  Google Scholar 

•• Myint AS, Dhadda AS, Stewart A, Mills J, Sripadam R, Rao C, et al. New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation. Colorectal Dis. 2022. Preliminary results of phase III trial which show significantly higher organ preservation rate with addition of contact X-ray brachytherapy boost to external beam radiotherapy compared to external beam radiotherapy alone.

Gerard JP, Dejean C, Montagne L, Benezery K, Doyen J, Hannoun Levi JM. A brief history of contact X-ray brachytherapy 50 kVp. Cancer Radiother. 2020;24(3):222–5.

Article  CAS  PubMed  Google Scholar 

• Stewart AJ, Van Limbergen EJ, Gerard JP, Appelt AL, Verhaegen F, Berbee M, et al. GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer. Clin Transl Radiat Oncol. 2022;33:15–22. Consensus guidelines on indications, definitions, technique, and follow up for contact X-ray brachytherapy. Includes recommendations on non operative management as well as palliative and definitive treatment.

Article  PubMed  Google Scholar 

Buckley H, Wilson C, Ajithkumar T. High-dose-rate brachytherapy in the management of operable rectal cancer: a systematic review. Int J Radiat Oncol Biol Phys. 2017;99(1):111–27.

Article  PubMed  Google Scholar 

Appelt AL, Ploen J, Harling H, Jensen FS, Jensen LH, Jorgensen JC, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015;16(8):919–27.

Article  PubMed  Google Scholar 

Dizdarevic E, Frostrup Hansen T, Ploen J, Henrik Jensen L, Lindebjerg J, Rafaelsen S, et al. Long-term patient-reported outcomes after high-dose chemoradiation therapy for nonsurgical management of distal rectal cancer. Int J Radiat Oncol Biol Phys. 2020;106(3):556–63.

Article  CAS  PubMed  Google Scholar 

Vuong T, Devic S, Moftah B, Evans M, Podgorsak EB. High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects. Brachytherapy. 2005;4(3):230–5.

Article  PubMed  Google Scholar 

Garant A, Magnan S, Devic S, Martin AG, Boutros M, Vasilevsky CA, et al. Image guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer. Int J Radiat Oncol Biol Phys. 2019;105(5):1005–11.

Article  PubMed  Google Scholar 

•• Garant A, Vasilevsky CA, Boutros M, Khosrow-Khavar F, Kavan P, Diec H, et al. MORPHEUS Phase II-III study: a pre-planned interim safety analysis and preliminary results. Cancers (Basel). 2022;14(15). Results from interim analysis of phase III trial which suggest significantly higher organ preservation with addition of high dose rate endorectal brachytherapy boost to external beam radiotherapy compared to external beam radiotherapy alone.

Couwenberg AM, Burbach JPM, Berbee M, Lacle MM, Arensman R, Raicu MG, et al. Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): a phase 2 randomized controlled trial. Int J Radiat Oncol Biol Phys. 2020;108(4):1008–18.

Article  PubMed  Google Scholar 

Jakobsen A, Ploen J, Vuong T, Appelt A, Lindebjerg J, Rafaelsen SR. Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses. Int J Radiat Oncol Biol Phys. 2012;84(4):949–54.

Article  PubMed  Google Scholar 

Rijkmans EC, Cats A, Nout RA, van den Bongard D, Ketelaars M, Buijsen J, et al. Endorectal brachytherapy boost after external beam radiation therapy in elderly or medically inoperable patients with rectal cancer: primary outcomes of the phase 1 HERBERT study. Int J Radiat Oncol Biol Phys. 2017;98(4):908–17.

Article  PubMed  Google Scholar 

Rijkmans EC, Marijnen CAM, van Triest B, Ketelaars M, Cats A, Inderson A, et al. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study. Radiother Oncol. 2019;133:176–82.

Article  PubMed  Google Scholar 

Devic S, Bekerat H, Garant A, Vuong T. Optimization of HDRBT boost dose delivery for patients with rectal cancer. Brachytherapy. 2019;18(4):559–63.